Ocuphire Pharma Inc.

NASDAQ: OCUP · Real-Time Price · USD
1.17
-0.16 (-12.03%)
At close: Oct 23, 2024, 10:00 PM

Ocuphire Pharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a 19.05M 39.85M 589K
Cost of Revenue
28M 6K 4K 4K
Gross Profit
-28M 19.04M 39.85M 585K
Operating Income
-62.07M -10.56M 18.23M -22.7M
Interest Income
n/a n/a n/a n/a
Pretax Income
-57.53M -9.97M 18.2M -56.69M
Net Income
-57.53M -9.99M 17.89M -56.53M
Selling & General & Admin
18.21M 11.95M 7.27M 8.12M
Research & Development
26.85M 17.65M 14.36M 15.17M
Other Expenses
n/a n/a -14K -157K
Operating Expenses
45.07M 29.61M 21.62M 23.29M
Interest Expense
n/a n/a 9K 2K
Selling & Marketing Expenses
n/a -6K n/a n/a
Cost & Expenses
73.07M 29.61M 21.62M 23.29M
Income Tax Expense
n/a 12K 315K -159K
Shares Outstanding (Basic)
26.72M 21.59M 19.93M 14.85M
Shares Outstanding (Diluted)
26.72M 21.59M 20.6M 14.85M
EPS (Basic)
-2.15 -0.46 0.90 -3.81
EPS (Diluted)
-2.15 -0.46 0.87 -3.81
EBITDA
-62.07M -9.97M 18.22M -56.69M
EBIT
n/a -9.97M 18.21M -56.69M
Depreciation & Amortization
n/a 6K 4K 4K